A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6600135.pdf
Reference16 articles.
1. Bower M, Newlands ES, Bleehen NM, Brada M, Begent RJ, Calvert H, Colquhoun I, Lewis P, Brampton MH (1997) Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma. Cancer Chemother Pharmacol 40: 484–488
2. Brada M, Hoang-Xuan K, Rampling R, Dietrich P-Y, Dirix L, Macdonald D, Heimans J, Zonnenberg B, Bravo-Marques J, Henriksson R, Stupp R, Yue N, Bruner J, Dugan M, Rao S, Zaknoen S (2001) Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol 12: 259–266
3. Dinnes J, Cave CB, Huang S, Major K, Milne RM (2001) The effectiveness and cost-effectiveness of temozolomide for the treatment of recurrent malignant glioma. Health Technol Assess 5: (13): 1–73
4. Galanis E, Buckner J (2000) Chemotherapy for high-grade gliomas. Br J Cancer 82: 1371–1380
5. Harris MT, Rosenthal MA, Ashley DL, Cher L (2001) An Australian experience with temozolomide for the treatment of recurrent high grade gliomas. J Clin Neurosci 8: 325–327
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Association of temozolomide with progressive multifocal leukoencephalopathy: a disproportionality analysis integrated with network pharmacology;Expert Opinion on Drug Safety;2023-11
2. Temozolomide Resistance: A Multifarious Review on Mechanisms Beyond O-6-Methylguanine-DNA Methyltransferase;CNS & Neurological Disorders - Drug Targets;2023-07
3. Effect of gedunin on glioblastoma proliferation and invasiveness:In vitroandin vivoapproaches;2023-06-05
4. Polymeric and small molecule-conjugates of temozolomide as improved therapeutic agents for glioblastoma multiforme;Journal of Controlled Release;2022-10
5. A Deep Dive: SIWV Tetra-Peptide Enhancing the Penetration of Nanotherapeutics into the Glioblastoma;ACS Biomaterials Science & Engineering;2021-07-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3